1O'Donnell AE, Barker AF,llowite JS, et al. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group [ J]. Chest, 1998,113 (5) :1329-1334.
2Wilson R. A vicious circle hypothesis operating during infective exacerbations ofchronic bronchitis [J]. Monaldi Arch Chest Dis, 1994,49 (2) : 159-164.
3Frey HR, Russi EW. Bronchiectasis-current aspects of an old disease [ J ]. Schweiz Med Wochenschr, 1997,127 (6) :219-230.
4Cole P. Host-microbe relationships in chronic respiratory infection [ J]. Respiration, 1989,55 ( Suppl 1 ) :5-8.
5Angrill J, Agustf C, de Celis R, et al. Bacterial colonisation in patients with bronchiectasis:microbiological pattern and risk factors [ J]. Thorax,2002,57 ( 1 ) : 15-19.
6Akira S, Hemmi H. Recognition of pathogen- associ- ated molecular patterns by TLR family[J]. Immunol lett, 2003,85 (2) : 85 - 95.
7Medzhitov R, Preston - Hurlburt P, Janeway C, et al. A human homologue of the Drosophia Toll protein signals activation of adaptive immunity[J]. Nature, 1997,388(6640) :323 - 324.
8Takeda K, Akira S. TLR signaling pathways[J]. Se min lmmunol,2004,16(1) :3 - 9.
9Akira S,Takeda K. Toll- like receptor signaling[J]. Nat Rev Immunol,2004,4(7) :499- 511.
10Miggin SM, O'Neill LA. New insights into the regula- tion of TLR signaling[J]. J leukoc Biol,2006,80(2): 220 - 226.
